Vertex Pharmaceuticals Incorporated - VRTX (NASDAQ-GS)

157.59
0.30 (-0.19%)
Quotes delayed 15 mins. Currently February 22, 2018 7:43:52 PM
By signing up, you can buy this stock for just $4.95 or purchase it within a Motif
Vertex Pharmaceuticals researches and develops small molecule drugs for the treatment of liver diseases and HIV/AIDS

Key Financials

Day Range:157.00 - 162.32
52 Week Range:84.39 - 174.96
Open:161.50
Shares:253.89M
Market Cap:40.01B
EPS:1.05
P/E Ratio:150.40
Div Yield:--
Performance
Previous close
No Chart Available
Purchase VRTX in a Motif
A motif is an intelligently weighted basket of up to 30 stocks and ETFs built around themes and investing styles.
On our platform, you can buy shares of VRTX not only as a single stock, but also as part of a motif.
Professional Motifs with VRTX
Biotech Breakthroughs
Biotech Breakthroughs 3.7% 1 YR RTN Biotech firms are breathing new life into hope for cures for complex diseases like cancer, arthritis and AIDS.
View all professional motifs with VRTX
Community Motifs with VRTX
Disease Buster 2
Disease Buster 2 15.2% 1 YR RTN
S&P Profit Screen 05L
S&P Profit Screen 05L 12.2% 1 YR RTN
Biotech Growth
Biotech Growth 2.9% 1 YR RTN
View all community motifs with VRTX
What Others Think About VRTX
Adam Feuerstein
$VRTX gets regulator sign-off on accelerated cystic fibrosis drug trial statnews.com/2018/02/21/ver… The company's execu… twitter.com/i/web/status/9…
22 49
US Banking News
Recent Analysts’ Ratings Updates for Vertex Pharmaceuticals $VRTX americanbankingnews.com/?p=5796152 #stocks
Transcript Daily
Virtus Fund Advisers LLC Raises Position in Vertex Pharmaceuticals Incorporated $VRTX zpr.io/nXNMJ
Allison Gatlin
Vertex Pharma could launch a cystic fibrosis treatment by 2019 $VRTX $GLPG $ABBV ow.ly/3PiL30iyJS9
Clark Joseph Kent
Vertex Pharma Could Launch A Cystic Fibrosis Treatment By 2019 $VRTX bit.ly/2EUTs2n
Breaking News Now
$VRTX $ABBV $GLPG :

Vertex Pharma Could Launch A Cystic Fibrosis Treatment By 2019:

StockNewsWires.com/vrtx-abbv-glpg…
sam biotech
@haodongvli @adamfeuerstein I am not sure why he hates $OMER so much, he is ok with 12 patients for $VRTX Ph3 but he complains about $OMER .
1
Related Companies Within The Biotechnology Sector
TIG
TiGenix - 41.92
TIG
Amgen Inc. - 182.45
AMGN
GILD
CELG
Biogen Inc. - 284.81
BIIB